Sciclone

Visual Financials
Company Name: SciClone Pharmaceuticals Inc
Ticker Symbol: SCLN
CIK Number: 0000880771
WWW Address: http://www.sciclone.com
CEO: Dr. Friedhelm Blobel,PhD
No. of Employees: 570
Common Issue Type: CS
Business Description:SciClone Pharmaceuticals, Inc. is a specialty pharmaceutical company with a substantial commercial business in China and a product portfolio of therapies for oncology, infectious diseases and cardiovascular among others.

 
Industry Information: DRUGS - Drug Manufacturers - Other [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 11.15 Unchanged 0.0 11.15 11.2  11.15 11.15 -
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 581.9 52.2 0.00 0.61 0.00 18.3 0.0 11.15 - 11.15
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close11.15$
PE Ratio - LTM18.3
Market Capitalisation581.9mil
Latest Shares Outstanding52.2mil
Earnings pS (EPS)0.61$
Dividend pS (DPS)0.00¢
Dividend Yield0.0%
Dividend Payout Ratio%
Revenue per Employee280,870$
Effective Tax Rate0.1%
Float44.9mil
Float as % of Shares Outstanding0.9%
Foreign Sales153mil
Domestic Sales8mil
Selling, General & Adm/tive (SG&A) as % of Revenue0.60%
Research & Devlopment (R&D) as % of Revenue0.10%
Gross Profit Margin85.7%
EBITDA Margin21.4%
Pre-Tax Profit Margin0.0%
Assets Turnover69.8%
Return on Assets (ROA)13.4%
Return on Equity (ROE)15.6%
Return on Capital Invested (ROCI)15.1%
Current Ratio7.4
Leverage Ratio (Assets/Equity)1.1
Interest Cover
Total Debt/Equity (Gearing Ratio)
LT Debt/Total Capital0.0%
Working Capital pS3.24$
Cash pS0.00$
Book-Value pS4.79$
Tangible Book-Value pS3.54$
Cash Flow pS0.68$
Free Cash Flow pS0.65$
KEY FIGURES (LTM): Price info
Price/Book Ratio2.33
Price/Tangible Book Ratio0.00
Price/Cash Flow16.5
Price/Free Cash Flow17.1
P/E as % of Industry Group114.0%
P/E as % of Sector Segment88.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Type of Payment-
Dividend Rate0.00
Current Dividend Yield0.0
5-Y Average Dividend Yield0.0
Payout Ratio0.0
5-Y Average Payout Ratio0.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week---0.0
4 Weeks11.1511.1511.150.0
13 Weeks11.1511.1511.150.0
26 Weeks11.1511.1511.150.0
52 Weeks11.1511.1511.150.0
YTD11.1511.15-0.0
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
11.1511.1511.1511.1511.150.000.00
 
GROWTH RATES5-Year
Growh
R² of 5-Year Growth3-Year
Growth
Revenue0.040.30.08
Income0.020.50.41
Dividend0.0
Capital Spending0.03NA0.54
R&D-19.15NA-25.74
Normalized Inc.0.00NA34.01
 
CHANGESYTD vs.
Last YTD
Curr Qtr vs.
Qtr 1-Yr ago
Annual vs.
Last Annual
Revenue %16.9-12.816.9
Earnings %-66.2-68.9-66.2
EPS %-68.0-72.7-68.0
EPS $-0.34-0.16-0.34
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio69.98
Current Ratio7.4
Quick Ratio (Acid Test)6.7
Liquidity Ratio (Cash)10.17
Receivables Turnover4.0
Average Collection Period90
Working Capital/Equity78.6
Working Capital pS3.29
Cash-Flow pS0.66
Free Cash-Flow pS0.64
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio15.33
Financial Leverage Ratio (Assets/Equity)0.0
Debt Ratio0.0
Total Debt/Equity (Gearing Ratio)0.00
LT Debt/Equity0.00
LT Debt/Capital Invested0.0
LT Debt/Total Liabilities0.0
Interest Cover0.0
Interest/Capital Invested0.00
 
VALUATION RATIOS
MULTIPLES
PQ Ratio0.00
Tobin's Q Ratio2.41
Current P/E Ratio - LTM18.30
Enterprise Value (EV)/EBITDA9.93
Enterprise Value (EV)/Free Cash Flow13.97
Dividend Yield0.0
Price/Tangible Book Ratio - LTM0.00
Price/Book Ratio - LTM2.33
Price/Cash Flow Ratio16.5
Price/Free Cash Flow Ratio - LTM17.1
Price/Sales Ratio0.00
P/E Ratio (1 month ago) - LTM29.6
P/E Ratio (26 weeks ago) - LTM6.2
P/E Ratio (52 weeks ago) - LTM14.0
5-Y High P/E Ratio18.5
5-Y Low P/E Ratio4.5
5-Y Average P/E Ratio0.0
Current P/E Ratio as % of 5-Y Average P/E19
P/E as % of Industry Group114.0
P/E as % of Sector Segment88.0
Current 12 Month Normalized P/E Ratio - LTM7.9
PER SHARE FIGURES
LT Debt pS0.00
Current Liabilities pS0.54
Tangible Book Value pS - LTM3.54
Book Value pS - LTM4.79
Capital Invested pS4.13
Cash pS - LTM0.00
Cash Flow pS - LTM0.68
Free Cash Flow pS - LTM0.65
Earnings pS (EPS)0.61
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin21.16
Free Cash Flow Margin 5YEAR AVG18.88
Net Profit Margin0.2
Net Profit Margin - 5YEAR AVRG.0.1
Equity Productivity0.74
Return on Equity (ROE)0.2
Return on Equity (ROE) - 5YEAR AVRG.0.1
Capital Invested Productivity0.74
Return on Capital Invested (ROCI)0.1
Return on Capital Invested (ROCI) - 5YEAR AVRG.0.1
Assets Productivity0.70
Return on Assets (ROA)0.1
Return on Assets (ROA) - 5YEAR AVRG.0.1
Gross Profit Margin85.7
Gross Profit Margin - 5YEAR AVRG.0.9
EBITDA Margin - LTM21.4
EBIT Margin - LTM20.8
Pre-Tax Profit Margin0.1
Pre-Tax Profit Margin - 5YEAR AVRG.0.1
Effective Tax Rate5.4
Effective Tax Rate - 5YEAR AVRG.-7.9
EFFICIENCY RATIOS
Cash Conversion Cycle450,264
Revenue per Employee280,870
Net Income per Employee53,911
Average Collection Period450,264
Receivables Turnover4.0
Day's Inventory Turnover Ratio
Inventory Turnover1.7
Inventory/Sales10.4
Accounts Payble/Sales2.28
Assets/Revenue1.43
Net Working Capital Turnover0.95
Fixed Assets Turnover3.47
Total Assets Turnover0.7
Revenue per $ Cash1.19
Revenue per $ Plant79.97
Revenue per $ Common Equity0.74
Revenue per $ Capital Invested0.74
Selling, General & Adm/tive (SG&A) as % of Revenue55.5
SG&A Expense as % of Revenue - 5YEAR AVRG.1.0
Research & Devlopment (R&D) as % of Revenue9.4
R&D Expense as % of Revenue - 5YEAR AVRG.9.4

  


Your Recent History
NASDAQ
SCLN
Sciclone
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.